MedTrace Logo

Questionnaire Pre-Test Study

NCT03248635 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2020-04-07

No results posted yet for this study

Summary

Background:

The Division of Cancer Epidemiology and Genetics does research into the causes of cancer and ways to prevent it. It uses data from questionnaires. Sometimes, pre-testing a questionnaire with a group of volunteers can help researchers find errors in it and learn ways to improve it.

Objectives:

To test a questionnaire for problems that might cause response errors and to develop ideas for improving it. To test how long it takes people to complete it.

Eligibility:

Adults ages 35-75. Volunteers both with and without a history of tobacco use and with or without a family history of cancer are needed.

Design:

Participants will be screened with a phone call.

Participants will be told what background data to bring to the 1 study visit.

An interviewer will give the participants the questionnaire. It will be done with pen and paper. It will take about 1 hour.

There will be multiple-choice and open-ended questions. They will be about lifestyle, medical, and environmental factors. Some of the questions will be about possibly illegal or highly sensitive behaviors.

Participants will note any questions that they find hard to answer for any reason. They will be asked to answer the best they can, but they can skip any question that they prefer not to answer.

The personal data of participants will be deleted when the study is done.

The interviewer will observe participants while they do the questionnaire. He or she will look for things like long pauses and confusion.

Participants will discuss the exam with the interviewer after they finish. This will take about 1 hour.

Conditions

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    lead NIH

Principal Investigators

  • Mark P Purdue, M.D. · National Cancer Institute (NCI)

Eligibility

Min Age
40 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-25
Primary Completion
2018-06-25
Completion
2020-04-02

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03248635 on ClinicalTrials.gov